drugset / Trial / NCT02579707
Food Effect Study of AG120 in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This will be a 2-part study. PART 1 is an open-label, randomized, food effect study of AG-120. Subjects will be enrolled to a fed/fasted or fasted/fed treatment sequence in a 2-period crossover design. PART 2 is an open-label study to determine the safety and PK parameters of a single 1000-mg oral dose of AG-120.
Timeline
- Start
- 2015-10
- Primary completion
- 2016-02
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivosidenib | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.